The system was never designed to know you

Hippocrates said it 2,400 years ago.

"It is more important to know which patient has the disease than to know which disease the patient has."

The father of medicine. The man whose oath every physician still swears at graduation. The origin point of the entire Western medical tradition.

He said: know the person first.

Then we built a system that does almost exactly the opposite.

Not through malice. Not through negligence. Through a specific sequence of choices - philosophical, industrial, statistical - each one reasonable on its own terms, each one compounding the one before it, until the accumulated weight of those choices produced a structure that is extraordinarily good at managing populations and quietly, systematically unable to see the individual standing inside them.

Before we go further, a precise distinction.

This is not an argument against medicine. When you break a bone, develop a bacterial infection, suffer a cardiac event, or face a surgical emergency - the system built over the past century is one of the most remarkable achievements in human history. Its capacity to respond to acute, discrete, visible crises with speed and precision has saved hundreds of millions of lives. You should use it. You should trust it for what it was designed to do.

The argument is narrower and more specific than medicine versus alternative.

It is this: the model that makes medicine extraordinary at acute care - standardised, population-based, designed for measurable discrete events - is the same model that makes it structurally ill-equipped for a different category of problem entirely. Chronic conditions. Complex, invisible, accumulated over years, shaped by variables the model was designed to exclude. Two fundamentally different problems. One model applied to both.

What follows is an investigation of that mismatch - how it was created, why it persists, and what it means for the person carrying something the system was never built to see.

If you have ever left a medical appointment carrying the same thing you walked in with - a symptom without a name, a fatigue that sleep does not fix, a body that insists something is wrong while the results insist everything is fine — you have felt the consequence of those choices.

Not the consequence of bad medicine.

The consequence of medicine working exactly as designed.

That distinction is the beginning of everything.

I. The philosophical error that was made 400 years before the evidence arrived

In 1641, René Descartes proposed something that seemed at the time like an elegant solution to a difficult problem.

The mind, he argued, is a thinking substance - res cogitans. The body is an extended substance - res extensa. They are fundamentally different kinds of things. The body is a machine. The mind is separate from it, operating through it but not of it.

This dualism gave science permission to study the body as a mechanical object without reference to the consciousness inhabiting it. It was philosophically convenient. It was scientifically productive. It made the body legible in ways it had not been before - you could dissect it, measure it, map its organs, understand its chemistry without the complicating presence of the person who owned it.

And it was, as the neuroscientist Antonio Damasio demonstrated three hundred and fifty years later, precisely wrong.

Damasio spent decades studying patients with damage to specific regions of the prefrontal cortex. These patients could reason normally in the abstract - their IQ was intact, their language was intact, their memory was intact. But they could not make functional decisions. Their personal lives collapsed. Their social judgment failed. They knew the right answer to ethical questions but could not translate knowing into choosing.

The missing component was somatic feedback. The body's continuous stream of biological signals - heart rate, gut tension, hormonal state, the thousand small physiological events that accompany emotional experience - had been disconnected from the reasoning process. Without that signal, reasoning became untethered. Accurate in the abstract. Useless in reality.

His book carried a title that named the error at the root of four centuries of scientific medicine: Descartes' Error.

The separation of mind and body, Damasio wrote, pervades both research and practice in medicine. The body is not a vehicle the mind happens to inhabit. The mind exists in and for an integrated organism. Remove the body from the equation and you do not get purer reasoning. You get a kind of reasoning that cannot actually function in a living life.

Medicine built itself on a philosophical error. Not out of ignorance - out of necessity. The Cartesian framework made the body scientifically tractable. It made medicine possible at scale. It also made medicine structurally unable to see what Gabor Maté has spent a career documenting: that the body and the history that lives inside it are not separate variables you can control for.

They are the same thing.

II. The industrial moment that made patients interchangeable

The Cartesian separation of mind from body gave medicine permission to treat the body as a machine. The industrial revolution gave it the organisational model for doing so at scale.

In the early twentieth century, the assembly line solved a problem that had no previous solution: how do you produce consistent outputs when the inputs are variable? When every worker, every material, every product is slightly different?

The answer was standardisation. You remove the individual variation. You break the process into discrete, measurable steps. You assign workers to specific tasks and measure outputs, not people. The product becomes reliable precisely because the individual has been removed from the equation.

The same logic migrated from the factory floor into medicine.

By 1985, a team of statisticians and economists at Harvard had developed the Resources-Based Relative Value Schedule - a payment system that applied industrial time-and-motion studies to clinical work. It dissected medical encounters into component parts, priced each one, and eliminated what could not be measured or standardized. By 1992, the United States government had adopted this system for Medicare.

A medical director at a major American hospital described his department's approach without apparent irony in a published medical journal: "We see the hospital as a factory and our hospitalist group as an assembly line that is in the business of manufacturing perfect discharges."

This is not a critique masquerading as a quote. It is a direct statement of organizational philosophy from within the institution.

The intellectual complement arrived in 1991 when Gordon Guyatt at McMaster University formalized what he initially called Scientific Medicine. His colleagues rejected the name - the implication that existing practice lacked scientific rigor was, he was told, unacceptable. He returned with a new name: Evidence-Based Medicine.

The term stuck. Within a decade it had transformed clinical practice across the Western world. It replaced expert opinion with something that felt more trustworthy: population data. The randomised controlled trial. The average treatment effect.

The logic was clean. Test a drug on a large group of people. Compare outcomes against a control group. Measure the average result. Build clinical guidelines from that average. Train physicians to follow those guidelines.

Hippocrates said know the patient. The industrial-statistical model said know the average.

These are not different routes to the same destination. They are different destinations entirely.

III. The patient who was excluded before you arrived

Every randomised controlled trial produces one number: the Average Treatment Effect.

This is what happens, statistically, across the population studied.

It tells you nothing about what will happen to you.

This is not a secret. It is documented, studied, widely published, and almost never mentioned in the examination room where you receive a prescription. Medicine even has a formal name for the phenomenon: Heterogeneity of Treatment Effects - the documented, acknowledged reality that individuals respond differently to the same treatment.

Here is what that acknowledgment means in practice.

A systematic review of clinical trials across 31 physical conditions found that the median exclusion rate from those trials was 77.1%. In type 2 diabetes trials - some of the most consequential prescribing in medicine - 81.7% of real-world patients would have been excluded from the studies their treatment is based on. Hypertension: 83% excluded. Asthma: 96%.

The people most consistently excluded? Those with age, multiple conditions, and multiple medications. Precisely the people most likely to be sitting in a doctor's office. Precisely the people for whom the question of treatment is most urgent.

In lipid-lowering trials - statins, among the most prescribed drugs in history - 71% of trials excluded women entirely. The drug prescribed to half the population was tested primarily on the other half.

This is not oversight. It is design. The most complex patients - the ones whose multiple conditions, multiple medications, and biological individuality introduced the most variables into the data - were excluded to protect the cleanliness of the research. The system optimized for scientific certainty about the average at the direct cost of clinical relevance to the individual.

None of this touches medicine's capacity to respond to acute crises. It touches everything about its capacity to respond to you, specifically, over time.

Seven percent of Caucasians carry a genetic variant that prevents them from metabolizing codeine into morphine. For those people, codeine produces no pain relief whatsoever. One in fourteen people of that ancestry receives nothing from a drug routinely prescribed for pain. The system has no standard protocol for identifying this before writing the prescription. It prescribes based on the average. It moves on.

On average, any given prescription drug on the market today works for approximately half of the people who take it. This is not from a critic of medicine. It is stated plainly by leading genomics research institutions as the acknowledged limitation of population-based prescribing.

The system knows this. It continues because it has no scalable alternative - yet.

IV. The body has been keeping a different account

While the system measures individual numbers against population averages, the body has been running a calculation of its own.

In 1993, the neuroscientist and endocrinologist Bruce McEwen named something that had been visible in clinical data for decades but had never been properly formalized. He called it allostatic load - the accumulated biological cost of sustained adaptation.

The concept requires a moment to understand, because it changes everything about how you read the information your body has been generating.

The body does not simply respond to stress and then return to baseline. It maintains stability through constant adjustment - allostasis, from the Greek for stability through change. When you encounter a demand, your body mobilizes: cortisol rises, inflammatory markers shift, cardiovascular parameters adjust, immune priorities reallocate. This is not dysfunction. This is the body working exactly as designed.

The problem is what happens when the demand is not acute but chronic. When the mobilisation becomes continuous. When adaptation itself becomes the ongoing state.

Allostatic load is the biological ledger of that sustained adaptation. It is measured not through any single marker but through the pattern across multiple systems simultaneously - neuroendocrine function, cardiovascular parameters, metabolic indicators, inflammatory tone, immune markers. McEwen's landmark research showed that higher allostatic load scores measured at baseline predicted, with statistical significance over a seven-year follow-up, mortality, cardiovascular disease, cognitive decline, and functional deterioration - independent of standard health status measures at the time of measurement.

The body was keeping score years before any single marker crossed a reference range.

Subsequent research demonstrated that high allostatic load in 2012 predicted multi-morbidity in 2016. That mid-life allostatic load is associated with brain structure changes detectable decades later. That childhood maltreatment predicts allostatic load in adulthood - the body's ledger begins earlier than any clinical encounter.

This is the measurement the standard blood panel does not take. The standard panel measures individual notes. Allostatic load is the symphony. And the symphony has been telling a story - specific, measurable, predictive - that the system was never designed to hear.

V. The two separations that science cannot justify

Gabor Maté has spent decades watching what happens when the allostatic ledger finally becomes visible as a diagnosis.

His patients arrive with names for their conditions: scleroderma, ALS, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, cancer. The system treats what can be measured - the immune dysfunction, the inflammatory cascade, the cellular abnormality. It does not ask what preceded the measurable event. It does not have a protocol for asking.

What Maté found, across hundreds of patients, was a pattern so consistent that he spent years trying to explain it away before accepting what the data was showing.

The people most likely to develop serious chronic illness were those who had learned, early in life, not to say no. Who had suppressed anger for so long it no longer registered as anger. Who could not distinguish between their own needs and the demands of others. Who had internalised, through perfectly understandable childhood adaptations, the habit of emotional self-effacement.

This is not pop psychology. It is documented psychoneuroimmunology - the science of how the mind's states translate into the body's chemistry. The repression of emotion produces measurable changes in cortisol secretion. Sustained cortisol elevation suppresses immune function. A compromised immune system loses its capacity to distinguish self from non-self. Autoimmune disease - the body attacking itself - is, in a specific biological sense, what happens when the immune system learns the same pattern the person has been living.

Maté made a precise charge against Western medicine. It has imposed two separations, he argued, that are not scientifically tenable - but that are structurally necessary for the population model to function.

The first: mind from body. The assumption that chronic illness has nothing to do with emotional and psychological experience. The field of psychoneuroimmunology has produced a large and irrefutable body of research showing this assumption to be false. The brain and body systems that process emotion are intimately connected with the hormonal apparatus, the nervous system, and the immune system. They are, functionally, the same system described from different angles.

The second: person from environment. The assumption that health can be understood without understanding the social, cultural, economic, and relational context in which a body lives. These factors are more important influences on health and longevity than the individual biomarkers the system was designed to measure.

You cannot run a randomised controlled trial on someone's childhood. You cannot standardize their history of emotional suppression, their relationship to their own anger, their thirty years of allostatic accumulation. So medicine excluded those variables. Not because they don't matter. Because they can't be controlled.

The intake form asks about your medications.

Your body has been keeping a different record.

VI. Between 25 and 50 percent

There is a statistic that should have caused a fundamental reckoning in medicine, and has not.

Between 25 and 50 percent of all presentations in primary care involve what medicine calls medically unexplained symptoms - physical symptoms in the absence of identifiable organic cause. In secondary care, the figure reaches 50 percent across many specialties.

Not 3 percent. Not a fringe phenomenon. Between a quarter and a half of everyone who walks into a medical setting presents with something the system cannot explain.

The ten most common symptoms that bring people to primary care - chest pain, fatigue, dizziness, headache, swelling, back pain, shortness of breath, insomnia, abdominal pain, numbness - account for 40 percent of all visits. Doctors can identify a biological cause for only 26 percent of these presentations.

Medicine's response to this has been to create a category. Medically Unexplained Symptoms. A formal clinical designation for suffering the system cannot see.

This category is not a diagnosis. It is the system's formal documentation of its own blind spot - the gap between what the body is expressing and what the measurement apparatus can capture. It is Descartes' error made administrative. The body, inseparable from its history and its emotional life and its allostatic ledger, presenting symptoms that a system designed to measure physical objects in isolation cannot explain.

And the people who receive this designation often internalize the implication the system does not intend to send but sends anyway.

Perhaps it is me.

Perhaps the suffering is not real.

Perhaps the problem is my perception of the problem rather than the problem itself.

This is the most damaging inheritance of the Cartesian framework. When the body speaks and the system cannot hear, the silence is filled by the patient's doubt about their own experience.

VII. The clinical encounter is a biological event

Here is the layer medicine has no protocol for.

The words a doctor uses in a consultation are not neutral informational events. They are biological inputs.

The nocebo effect - the negative counterpart to the placebo - is documented across thousands of clinical studies. When research participants are told to expect pain, they experience more pain than those given the same stimulus without the warning. The mechanism is not psychological in the dismissive sense. It is neurochemical. Verbally induced negative expectations activate the hypothalamic-pituitary-adrenal axis - the HPA system governing the stress response - and produce measurable increases in cortisol and ACTH. The words trigger the same biological cascade as an actual stressor.

A patient told they have a serious condition, handed a list of likely complications, spoken to as a body in decline rather than a system with regenerative capacity - this is not receiving neutral information. This is receiving a biological intervention with no pharmacological approval, no dosage calculation, no monitoring protocol.

Medicine has pharmacokinetics mapped to the molecular level. It knows precisely how each drug metabolizes in each tissue. It has no protocol for the biology of the clinical encounter itself.

Joe Dispenza's work on the neuroscience of belief and Bruce Lipton's research on the biology of perception converge on the same mechanism from different directions: what you believe about your own capacity to heal directly affects the physiology of healing. Not as metaphor. As documented biochemical reality. The internal chemical environment of your cells responds to perception and expectation. The nocebo effect is not the exception to this principle. It is the most measurable, most reproducible, most clinically concrete expression of it.

Every appointment ends with a biological event the system never measures.

Every diagnosis delivered without this understanding is an intervention whose full consequences remain unknown.

VIII. The eighteen-century gap, and where we are now

After the Hippocratic period, there was a gap of eighteen centuries in which individual medicine was largely abandoned and one-size-fits-all thinking dominated. The individual was lost to category. The patient became an instance of a condition rather than a person with a condition.

Then modern medicine arrived. And in its attempt to make clinical practice more rigorous - to replace anecdote with evidence, authority with data - it reinstated the population model with better statistics.

The randomised controlled trial solved the problem of anecdote and authority. It did not solve the problem Hippocrates was pointing at.

It also takes, on average, seventeen years for research evidence to reach clinical practice. Multiple independent studies converge on this number. The Institute of Medicine stated it formally in 2001. It has been confirmed repeatedly since. The doctor treating you today is working from a clinical consensus that in many cases reflects the state of knowledge from seventeen years ago. And research shows it takes even longer to de-adopt practices proven ineffective than to adopt new ones. The system is slow to add what is new. It is slower still to remove what is wrong.

There is a word for illness caused by the treatment itself. Iatrogenesis. Metformin - one of the most prescribed drugs in the world - systematically depletes vitamin B12 through a documented mechanism, producing peripheral neuropathy that looks identical to the diabetic neuropathy it was supposedly managing. Statins deplete CoQ10. Beta blockers interfere with melatonin synthesis. Proton pump inhibitors impair the absorption of magnesium, zinc, iron, and B12. The pattern is not the exception. It is the structure of what happens when a system designed to measure whether a target number moved correctly was never designed to ask what else moved while it was looking at that number.

IX. The system knows - and what that means for you

Medicine itself has begun to acknowledge what it cannot do.

In 2015, the United States launched the Precision Medicine Initiative - a formal national program built on the explicit recognition that the one-size-fits-all model is insufficient. Precision medicine integrates genomic data, environmental exposure, microbiome composition, wearable data, and lifestyle factors to move from population averages toward individual prediction. The global precision medicine market was estimated at $151 billion in 2024 and is projected to reach $469 billion by 2034.

Functional medicine - which asks why is this happening to this specific person rather than what drug matches this diagnostic category - is moving from alternative to mainstream. The Institute for Functional Medicine now trains physicians in a root-cause, systems-based approach that treats patients as individuals rather than categories.

Wearable technology is for the first time generating continuous, longitudinal, individual-level biological data. The most important comparison in your health has never been you versus a reference range. It is you versus yourself over time.

Medicine's own researchers have a term for what they are building toward: the N-of-1 trial. A clinical study of exactly one person. Measured against their own baseline. Over time. Valid scientific methodology. It is essentially what a personalised health system is.

The system knows this is where it needs to go. It simply cannot build it for every individual patient at scale.

That gap - between what the system knows is needed and what it can currently provide - is not a reason to reject medicine.

It is a precise description of the space this school exists to fill.

What you are now carrying

Medicine is not the enemy. Acute medicine - surgery, emergency care, infectious disease, trauma - remains one of the most powerful tools available to a human being in crisis. Use it. Trust it for what it was designed to do.

What this node has been about is different. It is about what happens after the acute crisis, or instead of it. When the problem is not a discrete event but an accumulated pattern. When the cause is not visible but systemic. When the symptom is real but the system's frame cannot see what produced it. When you sit in a waiting room rehearsing how to describe something that resists description, and leave fifteen minutes later carrying it still.

For those problems - which describe between a quarter and a half of everyone who walks into a primary care setting - a different kind of system is needed. One that was designed for the individual, not the average. One that can hold the body's full complexity, including the Cartesian variables the trial designs excluded. One that understands the clinical encounter itself as a biological event. One that can read the allostatic account the body has been keeping for decades, not just the individual markers that finally crossed a reference range.

That system does not exist yet as a medical institution. It is being built - in precision medicine research, in functional medicine practice, in the continuous biological data your wearable generates every night.

But it can exist now, for you, as a methodology. As a way of thinking about your health that the system cannot give you but that you can build for yourself.

You leave the waiting room the same way you came in.

But now you understand something you did not understand before.

Fine means not significantly different from the average of a population you may never have resembled. Normal means within a range established from data that would likely have excluded you. The treatment you were prescribed was tested on people from whom most of your biological and psychological complexity was removed before the study began. The words delivered in that consultation were biological events with no monitoring protocol. And the category your unexplained symptoms fall into - if they fall into any - is the system's formal documentation of its own limitations, not a verdict on your experience.

None of this is a reason to distrust medicine.

It is a reason to understand precisely what medicine can and cannot see.

And to build, alongside it and beyond it - with the same rigor, the same honesty about uncertainty, the same respect for evidence - a system designed for the only patient who has ever mattered.

You.

Not because the system failed you.

Because it was never designed for you.

And that is a different sentence entirely.

Here is the complete reference list for Node 01.